WORLD NEWS
Rattlesnake serum-protein mixtures were about 10 times as potent as commercial antivenom in tests
Combining four serum proteins that western diamondback rattlesnakes evolved against their own venom fully neutralized lethal rattlesnake-venom activity in experiments and was about ten times as potent by weight as the commercial comparator. Different FETUA proteins complemented one another against metalloproteinase toxins.
That does not make the mixture ready for snakebite patients. The work covered selected viper venoms under experimental conditions; human safety, dose, timing, immune response and persistence remain untested. Approved antivenom and emergency care remain the standard.
Why was a mixture needed?
Individual FETUAs reduced particular enzyme or bleeding effects but did not reliably stop lethality. Selected mixtures broadened protection.
What does ten times mean?
It is a potency-by-weight comparison with one sheep-derived rattlesnake antivenom, not ten times better outcomes for every toxin, species or patient.
How might manufacturing change?
Recombinant proteins could offer more defined ingredients than animal-immunization products, but production, storage and behaviour in the body still need testing.
Which toxins were covered?
The study focused on metalloproteinases. Viper venoms contain other toxin families, so this is not a universal antivenom.
What should a bitten person do?
Do not attempt self-treatment. Call emergency and poison services immediately, avoid cutting, suction and tourniquets, and follow clinicians.
Primary source and independent checks
Read in other languages
한국어 · English · Español · 日本語 · Tiếng Việt